Mifepristone: payments to doctors
Payments that named Mifepristone as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $237K
- Providers
- 3
- Transactions
- 14
- Average per transaction
- $16,925
The per-transaction average — $16,925 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3 providers the average total is $78,982, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Genbiopro, Inc. | $236,947 | 100.0% |